Ingevity Stock Crosses Above 50-Day Average, Analysts Weigh In

Shares of specialty chemicals company Ingevity (NYSE:NGVT) rise as stock price crosses above 50-day moving average

Apr. 1, 2026 at 8:33am

Got story updates? Submit your updates here. ›

Shares of Ingevity Corporation (NYSE:NGVT), a specialty chemicals and performance materials company, rose on Tuesday as the stock price crossed above its 50-day moving average. Wall Street analysts have provided mixed ratings on the stock, with some maintaining a 'Hold' recommendation while others see it as a 'Buy' or 'Sell'.

Why it matters

Ingevity's stock performance and analyst sentiment are closely watched by investors as the company operates in the specialty chemicals and materials sectors, which are important for various industries like paper, adhesives, coatings, and automotive emissions control. The stock crossing above its 50-day moving average could signal a potential upward trend, though analyst opinions remain divided.

The details

Ingevity shares traded as high as $72.74 on Tuesday before closing at $71.35, with a trading volume of 357,713 shares. The stock has a 50-day moving average of $69.54. Wall Street analysts have provided a range of ratings on Ingevity, with some maintaining a 'Hold' recommendation, while others have assigned 'Buy' or 'Sell' ratings. The company's performance and outlook will likely continue to be closely monitored by the investment community.

  • Ingevity's stock price crossed above its 50-day moving average on Tuesday, April 1, 2026.

The players

Ingevity Corporation

A specialty chemicals and performance materials company headquartered in North Charleston, South Carolina. The company operates two primary business units: Performance Chemicals and Performance Materials.

Zacks Research

An investment research firm that recently raised its rating on Ingevity to a 'hold' rating.

Weiss Ratings

A financial research firm that currently has a 'sell (d-)' rating on Ingevity's stock.

Wells Fargo & Company

A major financial services company that has increased its price target for Ingevity's stock to $75 and maintained an 'equal weight' rating.

Jefferies Financial Group

An investment banking firm that has a 'buy' rating and $82 price target on Ingevity's stock.

Got photos? Submit your photos here. ›

What they’re saying

“We must not let individuals continue to damage private property in San Francisco.”

— Robert Jenkins, San Francisco resident

“Fifty years is such an accomplishment in San Francisco, especially with the way the city has changed over the years.”

— Gordon Edgar, grocery employee

What’s next

Analysts will continue to monitor Ingevity's stock performance and provide updates on their ratings and price targets as the company reports its financial results and provides guidance for the future.

The takeaway

Ingevity's stock price movement and analyst sentiment reflect the ongoing dynamics in the specialty chemicals and materials sectors, which are important for various industries. Investors will likely continue to closely watch the company's performance and outlook as it navigates market conditions.